Trial Parameters
Condition Infertility, Female
Sponsor Fundación Santiago Dexeus Font
Study Type INTERVENTIONAL
Phase N/A
Enrollment 20
Sex FEMALE
Min Age 18 Years
Max Age 40 Years
Start Date 2024-10-31
Completion 2025-04
Interventions
Corifollitropin alfa (CFA) 150 mcg + Clomiphene Citrate (CC) 100 mg/day from D1Clomiphene Citrate (CC) 100 mg/day from D1Monitoring cycle
Brief Summary
The current prospective observational pilot study aims to evaluate the endocrine profile of a single-injection protocol (single CFA + daily oral administration of CC).
Eligibility Criteria
Inclusion Criteria: Age \<= 40 AMH (Anti-Mullerian Hormone) 1.2-3.5 ng/ml or AFC 7-20 No family history of hereditary or chromosomal diseases Body mass index (BMI) 18 to 30 kg/m2